Comparative evaluation of expanded criteria for patients with hepatocellular carcinoma beyond the Milan criteria undergoing living-related donor liver transplantation

Clinical Transplantation

Volumn 25, Issue 5, 2011, Pages

  Shirabe, Ken ^a   Taketomi, Akinobu ^a   Morita, Kazutoyo ^a   Soejima, Yuji ^a   Uchiyama, Hideaki ^a   Kayashima, Hiroto ^a   Ninomiya, Mizuki ^a   Toshima, Takeo ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Des gamma carboxy prothrombin; Expanded criteria; Hepatocellular carcinoma; Liver transplantation; Recurrence free survival; Up to seven criteria

Indexed keywords

DECARBOXYPROTHROMBIN;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER RECURRENCE; CANCER SIZE; CLINICAL ASSESSMENT TOOL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; LIVING RELATED DONOR LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MILAN CRITERIA; PREDICTIVE VALUE; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR DIFFERENTIATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RECURRENCE; SURVIVAL RATE; TOKYO; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80054116741     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01463.x     Document Type: Article

References (14)

1. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinoma. N Engl J Med 1996: 334: 693.
2. Furukawa H, Shimamura T, Suzuki T et al. Liver transplantation for hepatocellular carcinoma: the Japanese experience. J Hepatobiliary Pancreat Surg 2010: 17: 533.
3. Yao FY, Ferrell L, Bass NM et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001: 33: 1394.
4. Sugawara Y, Tamura S, Makuuchi M. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis 2007: 25: 310.
5. Takada Y, Ito T, Ueda M et al. Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria. Dig Dis 2007: 2: 299.
6. Taketomi A, Sanefuji K, Soejima Y et al. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation 2009: 87: 531.
7. Mazzaferro V, Llovet JM, Miceli R et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009: 10: 35.
8. AJCC. AJCC Cancer Staging Manual, 6th edn. New York: Springer, 2002.
9. Shimada M, Yonemura Y, Ijichi H et al. Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative des-gamma-carboxy prothrombin value. Transplant Proc 2005: 37: 1177.
10. Soejima Y, Taketomi A, Yoshizumi T et al. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation 2007: 83: 893.
11. Ravaioli M, Grazi GL, Piscaglia F et al. Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am J Transplant 2008: 8: 2547.
12. Yao FY, Kerlan RK Jr, Hirose R et al. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology 2008: 48: 819.
13. Shirabe K, Itoh S, Yoshizumi T et al. The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol 2007: 95: 235.
14. Suzuki M, Shiraha H, Fujikawa T et al. Des-[gamma]-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma. J Biol Chem 2005: 280: 6409.